Pfizer Inc. et al v. Natco Pharma, Inc. et al
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V. |
Natco Pharma, Inc. and Natco Pharma, Ltd. |
1:2021cv01466 |
October 19, 2021 |
U.S. District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on November 8, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Pro Hac Vice Attorneya Karen L. Beckman, Christopher J. Sorenson, B. Jefferson Boggs, Jr, and Andrew O. Larsen for Natco Pharma, Inc. and Natco Pharma, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
![]() |
Filing 11 MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Christopher J. Sorenson, Karen L. Beckman and Andrew O. Larsen - filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Delcollo, Renee) |
Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Natco Pharma Ltd. for Natco Pharma, Inc. filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Farnan, Kelly) |
Filing 9 ANSWER to #1 Complaint, and Affirmative Defenses by Natco Pharma, Inc., Natco Pharma, Ltd..(Farnan, Kelly) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 8 WAIVER OF SERVICE returned executed by Warner-Lambert Company LLC, Pfizer Inc., PF Prism IMB B.V.: For Natco Pharma, Ltd. waiver sent on 10/20/2021, answer due 12/20/2021. (Dellinger, Megan) |
Filing 7 WAIVER OF SERVICE returned executed by Warner-Lambert Company LLC, Pfizer Inc., PF Prism IMB B.V.: For Natco Pharma, Inc. waiver sent on 10/20/2021, answer due 12/20/2021. (Dellinger, Megan) |
Filing 6 Summons Issued with Magistrate Consent Notice attached as to Natco Pharma, Inc. on 10/19/2021; Natco Pharma, Ltd. on 10/19/2021. (Attachments: #1 Summons Issued)(apk) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF Prism IMB B.V., Warner-Lambert Company LLC filed by PF Prism IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (apk) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,065,250 B2. (apk) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/22/2021. Date of Expiration of Patent: 05/24/2036.Thirty Month Stay Deadline: 1/14/2024. (apk) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
Filing 1 COMPLAINT filed against Natco Pharma, Inc., Natco Pharma, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3723489.) - filed by Warner-Lambert Company LLC, Pfizer Inc., PF Prism IMB B.V. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk) |
Remark: MDL has been advised (apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.